A report is given of a series of bladder cancer cases examined for the oxidation capacity demonstrated by the use of debrisoquine. No overall association of poor and extensive metaboliser exists between bladder cancer patients and a control group. An absolute association between a benzidine exposed subgroup and metaboliser status exists, but the numbers are too small to indicate the true nature of this relationship.
No takes yet. Share an insight, caveat, or question.
Cartwright et al. (1984) studied this question.